Anticancer Therapies – News and Features

Researchers have discovered that a novel combination therapy promotes cancer cell death and tumor regression in pancreatic cancer.

Researchers report that 94% of patients treated with the gene therapy eli-cel for cerebral adrenoleukodystrophy (CALD) have maintained neurological function six years post-treatment.

Researchers discovered that antiviral enzymes induce early mutations in bladder cancer, and standard chemotherapy causes additional mutations. The study highlights the role of complex DNA rearrangements in treatment resistance.

A new graphene oxide platform that mimics the interactions between immune cells could stimulate CAR T cells to reproduce, making CAR T-cell therapy more effective.

A small molecular tag added to a drug molecule can make drugs normally administered through an IV effective as oral pills.

Natural killer T cells could be used to produce antitumor activity in solid tumors.

The chemotherapy drug 5-fluorouracil has different mechanisms of action in different cancers, a new study has found.

Researchers have illustrated that synthetic cannabis can reduce agitation in Alzheimer's patients by an average of 30%.

This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease treatment, according to a new published study in Cell.